Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (26)

1

Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study

enthalten in: Antiviral research | 2023

von Verbinnen, T. | Talloen, W. | Janssen, H. | +6

2

Genotypic and phenotypic characterization of influenza A viral variants in study participants treated with pimodivir in the phase 2b TOPAZ study

enthalten in: Antiviral therapy | 2023

von Vingerhoets, J. | Van Dromme, I. | van Duijnhoven, W. | +3

3

Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates

enthalten in: Nature | 2023

von Goethals, O. | Kaptein, S. | Kesteleyn, B. | +41

CommentIn: Nat Rev Drug Discov. 2023 May;22(5):355. - PMID 37020012

4

Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity : Evaluation of 5676 Phase 1 Passed Structures

enthalten in: Journal of medical virology | 2022

von Chiu, W. | Verschueren, L. | Van den Eynde, C. | +11

5

In vitro activity of itraconazole against SARS-CoV-2

enthalten in: Journal of medical virology | 2021

von Van Damme, E. | De Meyer, S. | Bojkova, D. | +8

6

Virology analysis of chronic hepatitis B virus-infected patients treated for 28 days with JNJ-56136379 monotherapy

enthalten in: Journal of viral hepatitis | 2020

von Verbinnen, T. | Hodari, M. | Talloen, W. | +7

7

Lack of antiviral activity of darunavir against SARS-CoV-2

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020

von De Meyer, S. | Bojkova, D. | Cinatl, J. | +5

8

Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845

enthalten in: Virology journal | 2017

von Vijgen, L. | Thys, K. | Vandebosch, A. | +3

9

In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Verbinnen, T. | Fevery, B. | Vijgen, L. | +3

10

Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2015

von Fevery, B. | Susser, S. | Lenz, O. | +7